1Filippi M, Rocca MA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis[ J]. 2005, J Neuroimaing, 15 (4 Suppl 1 ) :46 - 57.
2De Stefano N, Bartolozzi ML, Guidi L, et al. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis [J]. J Neurol Sci, 2005, 233( 1 -2):203 -208.
3Mader I, Seeger U, Weissert R, et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis[ J]. Brain, 2001 , 124 (pt5) :953 - 961.
4Lin A, Ross BD, Harris K, et al. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making[J]. Neuro Rx, 2005, 2(2) :197 -214.
5Srinivasan R, Sailasuta N, Hurd R, et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T[J]. Brain, 2005, 128(pt5) : 1016 - 1025.
6He J, Inglese M, Li BS, et al. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normalappearing white matter at MR imaging-initial experience[ J]. Radiology, 2005, 234( 1 ) :211 -217.
7Vrenken H, Barkhof F, Uitdehaag BM, et al. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter[J]. Magn Reson Med, 2005, 53 (2) :256 -266.
8Inglese M, Li BS, Rusinek H, et al. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis[ J ]. Magn Reson Med, 2003, 50(1):190-195.
9Siger-Zajdel M, Selmaj K. Proton magnetic resonance spectroscopy of normal appearing white matterin asymptomatic relatives of multiple sclerosis patients[ J]. European Journal of Neurology, 2006, 13(3) : 296 -298.
10Tiberio M, Chard DT, Altmann DR, et al. Metabolite changes in early relapsing-remitting multiple sclerosis :A two year follow-up study[J]. J Neurol, 2006,253(2): 224-230.
6Comston A, Coles A. Multiple sclerosis [ J ]. Lancet, 2008, 372 (9648) : 1502 - 1517.
7Belhnann-Strobl J, Stiepani H, Wuerfel J, et al. MR spectroscopy (MRS) and magnetisation transfer imaging (MTI) lesion load clinical scores in early relapsing remitting multiple sclerosis: a combined cross- sectional and longitudinal study[ J ]. Eur Radiol, 21309, 19 ( 8 ) : 2066 - 2074.
8McDonald W I, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis[ J]. Ann Neurol, 2001,50( 1 ) : 121 - 127.
9Tepavcevic D K, Pekmezovic T, Drulovic J. Quality of life assessment in patients with multiple sclerosis [J]. Vojnosanit Pregl, 2009, 66 (8) : 645 -650.
10Filippi M, Falini A, Arnold D L, et al. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology : consensus report of the white matter study group [ J ]. J Magn Reson Imaging, 2005, 21(6) : 669 -675.
